The De-identified Health Data Market will grow at highest pace owing to increasing demand
De-identified health data refers to health-related data that does not contain direct identifiers such as name, date of birth, Social Security number, phone number, and Photographic images. It has various advantages like it helps in secondary usage of data for research purposes and ensures privacy and security of patient information. The growing need for higher drug efficiency and reduced costs in clinical trials is increasing the demand for de-identified patient data. Access to such large real-world datasets can help discover novel biomarkers, enhance drug safety monitoring, and power meta-analyses.
The Global De-identified Health Data Market is estimated to be valued at US$ 8.21 Billion in 2025 and is expected to exhibit a CAGR of 9.3% over the forecast period 2025 To 2032.
Key Takeaways
Key players operating in the De-identified Health Data market are DEIDENTIFY, IBM Watson Health (Anthropic), Anthropic, Qure.ai.
De-Identified Health Data Market Growth for data-driven clinical research from pharmaceutical companies and clinical research organizations is one of the major factors driving market growth. De-identified health data provides real-world evidence and helps in secondary usage of data, fueling demand.
Technological advancements in data de-identification techniques like homomorphic encryption and advanced analytics are helping generate insights from large datasets without compromising privacy. This is boosting adoption of de-identified health data across various domains.
Market Trends
The market is witnessing increased adoption of real-world evidence solutions to supplement traditional clinical trial methodologies. De-identified health data is helping generate real-world evidence, attracting more stakeholders. Another trend is the growing partnership between data vendors, technology players, and end-users to expand datasets and build hybrid models.
Market Opportunities
Rising focus on value-based care and outcomes-based research is expected to create opportunities for players. The untapped potential of real-world data from regions like Asia-Pacific also provides lucrative growth prospects. Integration of AI/ML capabilities for advanced analytics of health data offers opportunities over the forecast period.
Impact of COVID-19 on De-identified Health Data Market Growth
The COVID-19 pandemic has accelerated the demand for de-identified health data. Several researchers and healthcare organizations are utilizing de-identified patient data to study the spread of the virus and its impact on different demographics. It is helping them gain valuable insights to develop vaccines and treatments. The sudden surge in research activities related to COVID-19 has boosted the consumption of de-identified data.
In the pre-COVID era, de-identified health data was predominantly used for non-COVID drug research and the development of novel treatment methods. The market was growing gradually as more hospitals and clinics adopted data de-identification and anonymization techniques to share data securely for research. However, the pandemic has increased the relevance and need for aggregated patient information. This has led to short-term spike as well as long-term sustainable growth opportunities for de-identified health data providers.
As the pandemic continues, the market is expected to grow further. Researchers will analyze long-term health impacts of COVID-19 infections using de-identified data. Pharmaceutical companies will use the insights to develop new drugs to fight emerging coronavirus variants. Additionally, governments and public health organizations will leverage the knowledge from data-driven research to prepare for future health emergencies. The learnings from the current crisis will encourage more effective utilization of de-identified patient data for pandemic preparedness.
Geographical Concentration of De-identified Health Data Market
In terms of value, North America accounts for the major share of the global de-identified health data market currently. This is due to the active research ecosystem and rapid technology adoption in the healthcare sectors of the United States and Canada. Major pharmaceutical companies and research institutions are driving the regional market growth by their increasing investment in real-world data infrastructure and analytics capabilities.
Fastest Growing Region in De-identified Health Data Market
Asia Pacific region is poised to witness the fastest growth in the de-identified health data market during the forecast period. Rapid economic development, growing patient volumes in hospitals of China and India, and rising focus on value-based care are some of the key factors fueling the APAC market. Additionally, improving data management regulations and ability to provide cost-efficient data analytics services will further accelerate the regional market expansion.
Get more insights on, De-identified Health Data Market
Get This Report in English Language: De-identified Health Data Market
Get This Report in Japanese Language: 非識別化健康データ市場
Get This Report in Korean Language: 비식별화된 건강 데이터 시장
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian